Cargando…
Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study
BACKGROUND: Benign prostatic hyperplasia (BPH), a common urological disease in aging men, frequently produces lower urinary tract symptoms (LUTS). Clinical studies have shown that terazosin relaxes the smooth muscle of the prostate and bladder, facilitates bladder emptying, improves LUTS, increases...
Autores principales: | Guzmán, Raúl, Fernández, Julio C., Pedroso, Manuel, Fernández, Lilia, Illnait, José, Mendoza, Sarahí, Quiala, Ana T., Rodríguez, Zunilda, Mena, Jilma, Rodíguez, Aylim, Campos, Marbelis, Sánchez, Carlos, Alvarez, Yanet, Jiménez, Gladys |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560798/ https://www.ncbi.nlm.nih.gov/pubmed/31217822 http://dx.doi.org/10.1177/1756287219854923 |
Ejemplares similares
-
Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia
por: Ohsfeldt, Robert L., et al.
Publicado: (2004) -
Intraoperative floppy iris syndrome associated with terazosin
por: Venkatesh, Rengaraj, et al.
Publicado: (2007) -
Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders
por: Liu, Jingjing, et al.
Publicado: (2021) -
The REGIA Database (RegiaDB): Status, Limitations and Future Developments
por: Alonso-Allende, Ramon, et al.
Publicado: (2002) -
Terazosin Treatment Induces Caspase-3 Expression in the Rat Ventral Prostate
por: Papadopoulos, Georgios, et al.
Publicado: (2013)